Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $56.9800 (-1.5%) ($56.9700 - $58.1100) on Fri. Dec. 9, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.27% (three month average) | RSI | 69 | Latest Price | $56.9800(-1.5%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO declines -0.8% a day on average for past five trading days. | Weekly Trend | HALO advances 2.6% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IBB(38%) IFRA(34%) IWO(34%) IWM(33%) IWN(31%) | Factors Impacting HALO price | HALO will decline at least -1.135% in a week (0% probabilities). VIXM(-11%) XBI(-7%) VXX(-6%) IGOV(-5%) GLD(-4%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.135% (StdDev 2.27%) | Hourly BBV | -1.2 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $56.94(0.07%) | 10 Day Moving Average | $57.22(-0.42%) | 20 Day Moving Average | $55.54(2.59%) | To recent high | -4% | To recent low | 47.7% | Market Cap | $7.788b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |